Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-08T13:39:57.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision label v3.7.0 was added to the record history, replacing the previous v3.6.6 entry.
    Difference
    0.0%
    Check dated 2026-09-17T19:05:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the history; the previous revision, v3.6.5, has been removed from the history.
    Difference
    0.0%
    Check dated 2026-09-03T13:49:20.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page history, replacing the previous v3.6.4. This represents a metadata update to the page rather than any substantive changes to study information.
    Difference
    0.0%
    Check dated 2026-08-13T01:55:10.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The history section now shows Revision: v3.6.4, replacing Revision: v3.6.3, reflecting a new version of the study record history.
    Difference
    0.0%
    Check dated 2026-07-22T09:54:28.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    The study history now shows the latest Revision: v3.6.3, replacing the previous Revision: v3.6.0.
    Difference
    0.0%
    Check dated 2026-07-01T02:46:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.